408 related articles for article (PubMed ID: 27142292)
1. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
[TBL] [Abstract][Full Text] [Related]
2. Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation.
Ulimoen SR; Enger S; Norseth J; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Clin Cardiol; 2014 Jul; 37(7):422-7. PubMed ID: 24700386
[TBL] [Abstract][Full Text] [Related]
3. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Eur Heart J; 2014 Feb; 35(8):517-24. PubMed ID: 24135831
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Hijazi Z; Siegbahn A; Andersson U; Granger CB; Alexander JH; Atar D; Gersh BJ; Mohan P; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L;
Circulation; 2014 Feb; 129(6):625-34. PubMed ID: 24226808
[TBL] [Abstract][Full Text] [Related]
8. The evidence regarding the drugs used for ventricular rate control.
Segal JB; McNamara RL; Miller MR; Kim N; Goodman SN; Powe NR; Robinson K; Yu D; Bass EB
J Fam Pract; 2000 Jan; 49(1):47-59. PubMed ID: 10678340
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.
Horjen AW; Ulimoen SR; Norseth J; Svendsen JH; Smith P; Arnesen H; Seljeflot I; Tveit A
Scand J Clin Lab Invest; 2018 Sep; 78(5):386-392. PubMed ID: 29933716
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Blagova OV; Nedostup AV
Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
[TBL] [Abstract][Full Text] [Related]
11. What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?
Anders B; Alonso A; Artemis D; Schäfer A; Ebert A; Kablau M; Fluechter S; Findeisen P; Hennerici MG; Fatar M
Cerebrovasc Dis; 2013; 36(3):211-7. PubMed ID: 24135532
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
Koh KK; Song JH; Kwon KS; Park HB; Baik SH; Park YS; In HH; Moon TH; Park GS; Cho SK
Int J Cardiol; 1995 Nov; 52(2):167-74. PubMed ID: 8749878
[TBL] [Abstract][Full Text] [Related]
13. High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation.
Horjen AW; Ulimoen SR; Seljeflot I; Smith P; Arnesen H; Norseth J; Tveit A
Cardiology; 2016; 133(4):233-8. PubMed ID: 26697854
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
[TBL] [Abstract][Full Text] [Related]
15. Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population.
Horjen AW; Ulimoen SR; Enger S; Berge T; Ihle-Hansen H; Norseth J; Tveit A
Scand J Clin Lab Invest; 2015 Jul; 75(4):308-13. PubMed ID: 25761493
[TBL] [Abstract][Full Text] [Related]
16. Which high-sensitivity troponin variable best characterizes infarct size and microvascular obstruction?
Schaaf M; Huet F; Akodad M; Gorce-Dupuy AM; Adda J; Macia JC; Delseny D; Leclercq F; Cristol JP; Marin G; Mewton N; Roubille F
Arch Cardiovasc Dis; 2019 May; 112(5):334-342. PubMed ID: 30777683
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
De Schryver N; Scavée C; Marchandise S; Pasquet A; de Meester C; le Polain de Waroux JB
Europace; 2014 Aug; 16(8):1125-30. PubMed ID: 24599938
[TBL] [Abstract][Full Text] [Related]
18. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.
Botto GL; Bonini W; Broffoni T
Clin Cardiol; 1998 Nov; 21(11):837-40. PubMed ID: 9825197
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation.
Sandberg F; Corino VD; Mainardi LT; Ulimoen SR; Enger S; Tveit A; Platonov PG; Sörnmo L
J Electrocardiol; 2015; 48(5):861-6. PubMed ID: 26275982
[TBL] [Abstract][Full Text] [Related]
20. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
